Harrison.ai is a trailblazing Australian healthtech company leveraging artificial intelligence to transform the future of healthcare. Founded in 2018 by brothers Dr. Aengus Tran, a former radiology registrar, and Dimitry Tran, a healthcare executive, Harrison.ai focuses on creating cutting-edge medical AI solutions that empower clinicians and improve patient outcomes. The company specializes in designing and deploying deep learning systems that significantly enhance medical decision-making across various specialties, including radiology and pathology.

The goal of Harrison.ai is to bridge the gap between AI technology and clinical practice. By working closely with clinicians and healthcare providers, the company ensures that the solutions it develops are not only technologically advanced but also clinically relevant. Harrison.ai follows a collaborative model called “AI-as-a-Service”, where they team up with medical institutions and diagnostic labs to develop scalable and effective AI models.

Core Areas of Focus

• Radiology: In collaboration with I-MED Radiology Network, one of Australia’s largest diagnostic imaging providers, Harrison.ai co-founded Annalise.ai. This joint venture focuses on applying AI to radiology scans, particularly chest X-rays and CTs, where the AI can detect over 100 different clinical findings with a high level of accuracy.
• Pathology: Harrison.ai expanded its reach to clinical pathology through another joint venture named Franklin.ai in partnership with Sonic Healthcare. The focus here is on building an AI system to assist pathologists in cancer diagnosis by analyzing tissue samples and reducing the workload on human experts.
• Expansion of AI research: Aside from radiology and pathology, the company invests heavily in R&D to explore other medical domains where AI can be applied meaningfully. This includes work in reproductive health, ophthalmology, and beyond.

Global Reach and Growth

Harrison.ai has grown rapidly and gained international attention for its innovative approach. With successful venture capital funding rounds totaling more than $120 million, the company is poised for global expansion. Their AI tools are now being adopted in hospitals and diagnostic labs not just in Australia but around the world. The company aims to impact millions of lives by building AI that augments human healthcare providers, improving diagnostic speed, accuracy, and capacity.

Clinical Collaboration and Validation

What sets Harrison.ai apart is its commitment to clinical validation and regulatory compliance. All products undergo rigorous clinical testing and regulatory approval, including CE marking in Europe. The company also maintains ongoing partnerships with hospitals and academic institutions to ensure that their AI solutions evolve in line with the latest medical knowledge, clinical guidelines, and ethical standards.

Ethical AI and Social Impact

Harrison.ai places strong emphasis on the ethical development of AI in healthcare. The company follows privacy-preserving practices in data handling and actively promotes transparent and explainable AI models. The team believes that AI should not replace doctors but empower them with tools that can help save more lives, especially in regions where healthcare resources are scarce.

Future Vision

Looking ahead, Harrison.ai aims to scale its impact horizontally across multiple medical disciplines and vertically by diving deeper into healthcare workflows. The company envisions a future where AI can help achieve more equitable, efficient, and high-quality care globally. With its successful track record and deep technological capabilities, Harrison.ai is positioned as one of the key players shaping the next generation of healthcare.

Frequently Asked Questions (FAQ)

• What is Harrison.ai?
  Harrison.ai is an Australian healthtech company that develops artificial intelligence solutions to assist in medical diagnosis and clinical decision-making.
• What are some major projects of Harrison.ai?
  Notable projects include Annalise.ai for radiology and Franklin.ai for pathology.
• Is Harrison.ai’s technology used in actual hospitals?
  Yes, their AI tools are being implemented in clinical settings both in Australia and internationally.
• How does Harrison.ai ensure medical accuracy?
  The company works closely with clinicians and follows strict regulatory validation and clinical testing processes.
• Does AI replace doctors in this model?
  No, the aim is to support and augment doctors, not to replace them. Harrison.ai builds tools to increase efficiency and accuracy in medical workflows.